Document Detail

The Stuttering Progress of Cell Therapy for Heart Disease.
MedLine Citation:
PMID:  21900888     Owner:  NLM     Status:  Publisher    
Stem cell therapy has emerged as a potential therapeutic strategy for myocardial infarction (MI). Multiple cell types used to regenerate the injured heart have been tested in clinical trials. The results of studies of skeletal myoblasts (SKMs) have been resoundingly negative, and the bone marrow-derived-cell experience leaves much to be desired. A number of lessons arise from the large-scale bone marrow-derived-cell trials: (i) efficacy has been inconsistent and, overall, modest; however, unexpectedly meaningful benefits on clinical end points have been reported; (ii) cardiac engraftment of cells is disappointingly low, and delivery methods need to be optimized and combined with strategies to boost retention; (iii) the cardiomyogenic potential of bone marrow cells is low; however, functional benefit can be achieved through indirect pathways; and (iv) autologous cell therapy has severe limitations; highly standardized allogeneic cell products are attractive. Given the spotty trajectory of cell therapy to date, a more systematic approach to product development and preclinical optimization will facilitate more effective clinical translation.
K Malliaras; M Kreke; E Marbán
Related Documents :
2911608 - Lysozyme-induced inhibition of the lymphocyte response to mitogenic lectins.
21929978 - Partial splenectomy but not total splenectomy preserves immunoglobulin m memory b cells...
22162718 - Regulatory t cells accumulate in the lung allergic inflammation and efficiently suppres...
3494068 - Defect in production of b cell differentiation factor-like activity by mononuclear cell...
17365508 - Dominance of the alpha1b-adrenergic receptor and its subcellular localization in human ...
24298368 - Clinical neurofunctional rehabilitation of a cat with spinal cord injury after hemilami...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-9-07
Journal Detail:
Title:  Clinical pharmacology and therapeutics     Volume:  -     ISSN:  1532-6535     ISO Abbreviation:  -     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-9-8     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372741     Medline TA:  Clin Pharmacol Ther     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Cedars-Sinai Heart Institute, Los Angeles, California, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prolonged Use of Aspirin Alters Human and Rat Intestinal Cells and Thereby Limits the Absorption of ...
Next Document:  Increasing Tamoxifen Dose in Breast Cancer Patients Based on CYP2D6 Genotypes and Endoxifen Levels: ...